Skip to content
Screener

Omnicell OMCL Operating Cash Flow

Operating Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
$213M+210%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$776M-51.1%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$122.94M+21.0%
Cardinal Health logo
Cardinal HealthCAH
$1.82B-37.6%
ICU Medical logo
ICU MedicalICUI
$80.15M+615%
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$34.2M+25.5%

Other financials

Income statement

See full
Revenue$312.2M+7.4%
Gross profit$152.9M+19.8%
Operating income$32.4M+300%
Net income$24.3M+331%
EPS (diluted)$0.52+333%

Balance sheet

See full
Cash & equivalents$322.8M-25.2%
Total debt$31.8M-25.4%
Total equity$1.3B+2.2%
Total assets$2.0B-6.8%

Cash flow

See full
CapEx$8.9M-24.1%
Free cash flow$59.4M+91.7%

Valuation

See full
Market cap$1.65B+13.3%
Enterprise value$1.36B+27.3%
P/E35.3×
P/S1.3×+0.1×

Profitability

See full
Gross margin44.8%+1.0pp
Operating margin4.6%+3.3pp
Net margin1.7%+1.1pp
FCF margin11.4%+2.1pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Omnicell’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000926326-26-000022
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Deferred revenues13,09815,103
Operating lease liabilities(5,966)(5,831)
Other long-term liabilities1,175753
Net cash provided by operating activities122,81468,679
Investing Activities
External-use software development costs(7,023)(8,709)
Purchases of property and equipment(21,375)(22,953)
Net cash used in investing activities(28,398)(31,662)

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Omnicell's operating cash flow?
Omnicell (OMCL) reported operating cash flow of $68.31M in Q2 2026.
How has Omnicell's operating cash flow changed year-over-year?
Omnicell's operating cash flow increased by 59.8% year-over-year, from $42.76M to $68.31M.
What is the long-term trend for Omnicell's operating cash flow?
Over 4 years (2021 to 2025), Omnicell's operating cash flow has grown at a -13.9% compound annual growth rate (CAGR), from $231.81M to $127.3M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Omnicell's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude